0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oncology Drug Discovery Services Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-25E5775
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Oncology Drug Discovery Services Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Oncology Drug Discovery Services Market Research Report 2025

Code: QYRE-Auto-25E5775
Report
June 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oncology Drug Discovery Services Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Oncology Drug Discovery Services Market

Oncology Drug Discovery Services Market

The global market for Oncology Drug Discovery Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The Oncology Drug Discovery Service is dedicated to oncology research, providing high-quality, timely and cost-effective oncology drug discovery and accelerating the development of the immunooncology product portfolio to develop new drugs that benefit human health.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oncology Drug Discovery Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Drug Discovery Services.
The Oncology Drug Discovery Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncology Drug Discovery Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncology Drug Discovery Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Oncology Drug Discovery Services Market Report

Report Metric Details
Report Name Oncology Drug Discovery Services Market
CAGR 5%
Segment by Type
  • Identification Service
  • Authentication Service
  • Hit-to-lead and Lead Optimization Services
  • Others
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Charles River, Evotec, GE Healthcare Life Sciences, GenScript, Horizon Discovery, TCG Lifesciences, Zumutor, ChemPartner, Aquila BioMedical, Onconova, Vichem Chemie, GVK Biosciences, NuChem Therapeutics, Syncom, Envigo, DiverChim, Aurora, HD Biosciences, WuXi AppTec
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Oncology Drug Discovery Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Oncology Drug Discovery Services Market report?

Ans: The main players in the Oncology Drug Discovery Services Market are Charles River, Evotec, GE Healthcare Life Sciences, GenScript, Horizon Discovery, TCG Lifesciences, Zumutor, ChemPartner, Aquila BioMedical, Onconova, Vichem Chemie, GVK Biosciences, NuChem Therapeutics, Syncom, Envigo, DiverChim, Aurora, HD Biosciences, WuXi AppTec

What are the Application segmentation covered in the Oncology Drug Discovery Services Market report?

Ans: The Applications covered in the Oncology Drug Discovery Services Market report are Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Others

What are the Type segmentation covered in the Oncology Drug Discovery Services Market report?

Ans: The Types covered in the Oncology Drug Discovery Services Market report are Identification Service, Authentication Service, Hit-to-lead and Lead Optimization Services, Others

Recommended Reports

Oncology Therapeutics

Drug Discovery Services

Oncology Diagnostics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Drug Discovery Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Identification Service
1.2.3 Authentication Service
1.2.4 Hit-to-lead and Lead Optimization Services
1.2.5 Others
1.3 Market by Application
1.3.1 Global Oncology Drug Discovery Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Research Institutes
1.3.3 Pharmaceutical Companies
1.3.4 Biotechnology Companies
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology Drug Discovery Services Market Perspective (2020-2031)
2.2 Global Oncology Drug Discovery Services Growth Trends by Region
2.2.1 Global Oncology Drug Discovery Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oncology Drug Discovery Services Historic Market Size by Region (2020-2025)
2.2.3 Oncology Drug Discovery Services Forecasted Market Size by Region (2026-2031)
2.3 Oncology Drug Discovery Services Market Dynamics
2.3.1 Oncology Drug Discovery Services Industry Trends
2.3.2 Oncology Drug Discovery Services Market Drivers
2.3.3 Oncology Drug Discovery Services Market Challenges
2.3.4 Oncology Drug Discovery Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Drug Discovery Services Players by Revenue
3.1.1 Global Top Oncology Drug Discovery Services Players by Revenue (2020-2025)
3.1.2 Global Oncology Drug Discovery Services Revenue Market Share by Players (2020-2025)
3.2 Global Oncology Drug Discovery Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oncology Drug Discovery Services Revenue
3.4 Global Oncology Drug Discovery Services Market Concentration Ratio
3.4.1 Global Oncology Drug Discovery Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Drug Discovery Services Revenue in 2024
3.5 Global Key Players of Oncology Drug Discovery Services Head office and Area Served
3.6 Global Key Players of Oncology Drug Discovery Services, Product and Application
3.7 Global Key Players of Oncology Drug Discovery Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Drug Discovery Services Breakdown Data by Type
4.1 Global Oncology Drug Discovery Services Historic Market Size by Type (2020-2025)
4.2 Global Oncology Drug Discovery Services Forecasted Market Size by Type (2026-2031)
5 Oncology Drug Discovery Services Breakdown Data by Application
5.1 Global Oncology Drug Discovery Services Historic Market Size by Application (2020-2025)
5.2 Global Oncology Drug Discovery Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oncology Drug Discovery Services Market Size (2020-2031)
6.2 North America Oncology Drug Discovery Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oncology Drug Discovery Services Market Size by Country (2020-2025)
6.4 North America Oncology Drug Discovery Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncology Drug Discovery Services Market Size (2020-2031)
7.2 Europe Oncology Drug Discovery Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oncology Drug Discovery Services Market Size by Country (2020-2025)
7.4 Europe Oncology Drug Discovery Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Drug Discovery Services Market Size (2020-2031)
8.2 Asia-Pacific Oncology Drug Discovery Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oncology Drug Discovery Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Oncology Drug Discovery Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncology Drug Discovery Services Market Size (2020-2031)
9.2 Latin America Oncology Drug Discovery Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oncology Drug Discovery Services Market Size by Country (2020-2025)
9.4 Latin America Oncology Drug Discovery Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Drug Discovery Services Market Size (2020-2031)
10.2 Middle East & Africa Oncology Drug Discovery Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oncology Drug Discovery Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Oncology Drug Discovery Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Oncology Drug Discovery Services Introduction
11.1.4 Charles River Revenue in Oncology Drug Discovery Services Business (2020-2025)
11.1.5 Charles River Recent Development
11.2 Evotec
11.2.1 Evotec Company Details
11.2.2 Evotec Business Overview
11.2.3 Evotec Oncology Drug Discovery Services Introduction
11.2.4 Evotec Revenue in Oncology Drug Discovery Services Business (2020-2025)
11.2.5 Evotec Recent Development
11.3 GE Healthcare Life Sciences
11.3.1 GE Healthcare Life Sciences Company Details
11.3.2 GE Healthcare Life Sciences Business Overview
11.3.3 GE Healthcare Life Sciences Oncology Drug Discovery Services Introduction
11.3.4 GE Healthcare Life Sciences Revenue in Oncology Drug Discovery Services Business (2020-2025)
11.3.5 GE Healthcare Life Sciences Recent Development
11.4 GenScript
11.4.1 GenScript Company Details
11.4.2 GenScript Business Overview
11.4.3 GenScript Oncology Drug Discovery Services Introduction
11.4.4 GenScript Revenue in Oncology Drug Discovery Services Business (2020-2025)
11.4.5 GenScript Recent Development
11.5 Horizon Discovery
11.5.1 Horizon Discovery Company Details
11.5.2 Horizon Discovery Business Overview
11.5.3 Horizon Discovery Oncology Drug Discovery Services Introduction
11.5.4 Horizon Discovery Revenue in Oncology Drug Discovery Services Business (2020-2025)
11.5.5 Horizon Discovery Recent Development
11.6 TCG Lifesciences
11.6.1 TCG Lifesciences Company Details
11.6.2 TCG Lifesciences Business Overview
11.6.3 TCG Lifesciences Oncology Drug Discovery Services Introduction
11.6.4 TCG Lifesciences Revenue in Oncology Drug Discovery Services Business (2020-2025)
11.6.5 TCG Lifesciences Recent Development
11.7 Zumutor
11.7.1 Zumutor Company Details
11.7.2 Zumutor Business Overview
11.7.3 Zumutor Oncology Drug Discovery Services Introduction
11.7.4 Zumutor Revenue in Oncology Drug Discovery Services Business (2020-2025)
11.7.5 Zumutor Recent Development
11.8 ChemPartner
11.8.1 ChemPartner Company Details
11.8.2 ChemPartner Business Overview
11.8.3 ChemPartner Oncology Drug Discovery Services Introduction
11.8.4 ChemPartner Revenue in Oncology Drug Discovery Services Business (2020-2025)
11.8.5 ChemPartner Recent Development
11.9 Aquila BioMedical
11.9.1 Aquila BioMedical Company Details
11.9.2 Aquila BioMedical Business Overview
11.9.3 Aquila BioMedical Oncology Drug Discovery Services Introduction
11.9.4 Aquila BioMedical Revenue in Oncology Drug Discovery Services Business (2020-2025)
11.9.5 Aquila BioMedical Recent Development
11.10 Onconova
11.10.1 Onconova Company Details
11.10.2 Onconova Business Overview
11.10.3 Onconova Oncology Drug Discovery Services Introduction
11.10.4 Onconova Revenue in Oncology Drug Discovery Services Business (2020-2025)
11.10.5 Onconova Recent Development
11.11 Vichem Chemie
11.11.1 Vichem Chemie Company Details
11.11.2 Vichem Chemie Business Overview
11.11.3 Vichem Chemie Oncology Drug Discovery Services Introduction
11.11.4 Vichem Chemie Revenue in Oncology Drug Discovery Services Business (2020-2025)
11.11.5 Vichem Chemie Recent Development
11.12 GVK Biosciences
11.12.1 GVK Biosciences Company Details
11.12.2 GVK Biosciences Business Overview
11.12.3 GVK Biosciences Oncology Drug Discovery Services Introduction
11.12.4 GVK Biosciences Revenue in Oncology Drug Discovery Services Business (2020-2025)
11.12.5 GVK Biosciences Recent Development
11.13 NuChem Therapeutics
11.13.1 NuChem Therapeutics Company Details
11.13.2 NuChem Therapeutics Business Overview
11.13.3 NuChem Therapeutics Oncology Drug Discovery Services Introduction
11.13.4 NuChem Therapeutics Revenue in Oncology Drug Discovery Services Business (2020-2025)
11.13.5 NuChem Therapeutics Recent Development
11.14 Syncom
11.14.1 Syncom Company Details
11.14.2 Syncom Business Overview
11.14.3 Syncom Oncology Drug Discovery Services Introduction
11.14.4 Syncom Revenue in Oncology Drug Discovery Services Business (2020-2025)
11.14.5 Syncom Recent Development
11.15 Envigo
11.15.1 Envigo Company Details
11.15.2 Envigo Business Overview
11.15.3 Envigo Oncology Drug Discovery Services Introduction
11.15.4 Envigo Revenue in Oncology Drug Discovery Services Business (2020-2025)
11.15.5 Envigo Recent Development
11.16 DiverChim
11.16.1 DiverChim Company Details
11.16.2 DiverChim Business Overview
11.16.3 DiverChim Oncology Drug Discovery Services Introduction
11.16.4 DiverChim Revenue in Oncology Drug Discovery Services Business (2020-2025)
11.16.5 DiverChim Recent Development
11.17 Aurora
11.17.1 Aurora Company Details
11.17.2 Aurora Business Overview
11.17.3 Aurora Oncology Drug Discovery Services Introduction
11.17.4 Aurora Revenue in Oncology Drug Discovery Services Business (2020-2025)
11.17.5 Aurora Recent Development
11.18 HD Biosciences
11.18.1 HD Biosciences Company Details
11.18.2 HD Biosciences Business Overview
11.18.3 HD Biosciences Oncology Drug Discovery Services Introduction
11.18.4 HD Biosciences Revenue in Oncology Drug Discovery Services Business (2020-2025)
11.18.5 HD Biosciences Recent Development
11.19 WuXi AppTec
11.19.1 WuXi AppTec Company Details
11.19.2 WuXi AppTec Business Overview
11.19.3 WuXi AppTec Oncology Drug Discovery Services Introduction
11.19.4 WuXi AppTec Revenue in Oncology Drug Discovery Services Business (2020-2025)
11.19.5 WuXi AppTec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Oncology Drug Discovery Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Identification Service
 Table 3. Key Players of Authentication Service
 Table 4. Key Players of Hit-to-lead and Lead Optimization Services
 Table 5. Key Players of Others
 Table 6. Global Oncology Drug Discovery Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Oncology Drug Discovery Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Oncology Drug Discovery Services Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Oncology Drug Discovery Services Market Share by Region (2020-2025)
 Table 10. Global Oncology Drug Discovery Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Oncology Drug Discovery Services Market Share by Region (2026-2031)
 Table 12. Oncology Drug Discovery Services Market Trends
 Table 13. Oncology Drug Discovery Services Market Drivers
 Table 14. Oncology Drug Discovery Services Market Challenges
 Table 15. Oncology Drug Discovery Services Market Restraints
 Table 16. Global Oncology Drug Discovery Services Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Oncology Drug Discovery Services Market Share by Players (2020-2025)
 Table 18. Global Top Oncology Drug Discovery Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Drug Discovery Services as of 2024)
 Table 19. Ranking of Global Top Oncology Drug Discovery Services Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Oncology Drug Discovery Services Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Oncology Drug Discovery Services, Headquarters and Area Served
 Table 22. Global Key Players of Oncology Drug Discovery Services, Product and Application
 Table 23. Global Key Players of Oncology Drug Discovery Services, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Oncology Drug Discovery Services Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Oncology Drug Discovery Services Revenue Market Share by Type (2020-2025)
 Table 27. Global Oncology Drug Discovery Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Oncology Drug Discovery Services Revenue Market Share by Type (2026-2031)
 Table 29. Global Oncology Drug Discovery Services Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Oncology Drug Discovery Services Revenue Market Share by Application (2020-2025)
 Table 31. Global Oncology Drug Discovery Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Oncology Drug Discovery Services Revenue Market Share by Application (2026-2031)
 Table 33. North America Oncology Drug Discovery Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Oncology Drug Discovery Services Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Oncology Drug Discovery Services Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Oncology Drug Discovery Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Oncology Drug Discovery Services Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Oncology Drug Discovery Services Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Oncology Drug Discovery Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Oncology Drug Discovery Services Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Oncology Drug Discovery Services Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Oncology Drug Discovery Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Oncology Drug Discovery Services Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Oncology Drug Discovery Services Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Oncology Drug Discovery Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Oncology Drug Discovery Services Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Oncology Drug Discovery Services Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Charles River Company Details
 Table 49. Charles River Business Overview
 Table 50. Charles River Oncology Drug Discovery Services Product
 Table 51. Charles River Revenue in Oncology Drug Discovery Services Business (2020-2025) & (US$ Million)
 Table 52. Charles River Recent Development
 Table 53. Evotec Company Details
 Table 54. Evotec Business Overview
 Table 55. Evotec Oncology Drug Discovery Services Product
 Table 56. Evotec Revenue in Oncology Drug Discovery Services Business (2020-2025) & (US$ Million)
 Table 57. Evotec Recent Development
 Table 58. GE Healthcare Life Sciences Company Details
 Table 59. GE Healthcare Life Sciences Business Overview
 Table 60. GE Healthcare Life Sciences Oncology Drug Discovery Services Product
 Table 61. GE Healthcare Life Sciences Revenue in Oncology Drug Discovery Services Business (2020-2025) & (US$ Million)
 Table 62. GE Healthcare Life Sciences Recent Development
 Table 63. GenScript Company Details
 Table 64. GenScript Business Overview
 Table 65. GenScript Oncology Drug Discovery Services Product
 Table 66. GenScript Revenue in Oncology Drug Discovery Services Business (2020-2025) & (US$ Million)
 Table 67. GenScript Recent Development
 Table 68. Horizon Discovery Company Details
 Table 69. Horizon Discovery Business Overview
 Table 70. Horizon Discovery Oncology Drug Discovery Services Product
 Table 71. Horizon Discovery Revenue in Oncology Drug Discovery Services Business (2020-2025) & (US$ Million)
 Table 72. Horizon Discovery Recent Development
 Table 73. TCG Lifesciences Company Details
 Table 74. TCG Lifesciences Business Overview
 Table 75. TCG Lifesciences Oncology Drug Discovery Services Product
 Table 76. TCG Lifesciences Revenue in Oncology Drug Discovery Services Business (2020-2025) & (US$ Million)
 Table 77. TCG Lifesciences Recent Development
 Table 78. Zumutor Company Details
 Table 79. Zumutor Business Overview
 Table 80. Zumutor Oncology Drug Discovery Services Product
 Table 81. Zumutor Revenue in Oncology Drug Discovery Services Business (2020-2025) & (US$ Million)
 Table 82. Zumutor Recent Development
 Table 83. ChemPartner Company Details
 Table 84. ChemPartner Business Overview
 Table 85. ChemPartner Oncology Drug Discovery Services Product
 Table 86. ChemPartner Revenue in Oncology Drug Discovery Services Business (2020-2025) & (US$ Million)
 Table 87. ChemPartner Recent Development
 Table 88. Aquila BioMedical Company Details
 Table 89. Aquila BioMedical Business Overview
 Table 90. Aquila BioMedical Oncology Drug Discovery Services Product
 Table 91. Aquila BioMedical Revenue in Oncology Drug Discovery Services Business (2020-2025) & (US$ Million)
 Table 92. Aquila BioMedical Recent Development
 Table 93. Onconova Company Details
 Table 94. Onconova Business Overview
 Table 95. Onconova Oncology Drug Discovery Services Product
 Table 96. Onconova Revenue in Oncology Drug Discovery Services Business (2020-2025) & (US$ Million)
 Table 97. Onconova Recent Development
 Table 98. Vichem Chemie Company Details
 Table 99. Vichem Chemie Business Overview
 Table 100. Vichem Chemie Oncology Drug Discovery Services Product
 Table 101. Vichem Chemie Revenue in Oncology Drug Discovery Services Business (2020-2025) & (US$ Million)
 Table 102. Vichem Chemie Recent Development
 Table 103. GVK Biosciences Company Details
 Table 104. GVK Biosciences Business Overview
 Table 105. GVK Biosciences Oncology Drug Discovery Services Product
 Table 106. GVK Biosciences Revenue in Oncology Drug Discovery Services Business (2020-2025) & (US$ Million)
 Table 107. GVK Biosciences Recent Development
 Table 108. NuChem Therapeutics Company Details
 Table 109. NuChem Therapeutics Business Overview
 Table 110. NuChem Therapeutics Oncology Drug Discovery Services Product
 Table 111. NuChem Therapeutics Revenue in Oncology Drug Discovery Services Business (2020-2025) & (US$ Million)
 Table 112. NuChem Therapeutics Recent Development
 Table 113. Syncom Company Details
 Table 114. Syncom Business Overview
 Table 115. Syncom Oncology Drug Discovery Services Product
 Table 116. Syncom Revenue in Oncology Drug Discovery Services Business (2020-2025) & (US$ Million)
 Table 117. Syncom Recent Development
 Table 118. Envigo Company Details
 Table 119. Envigo Business Overview
 Table 120. Envigo Oncology Drug Discovery Services Product
 Table 121. Envigo Revenue in Oncology Drug Discovery Services Business (2020-2025) & (US$ Million)
 Table 122. Envigo Recent Development
 Table 123. DiverChim Company Details
 Table 124. DiverChim Business Overview
 Table 125. DiverChim Oncology Drug Discovery Services Product
 Table 126. DiverChim Revenue in Oncology Drug Discovery Services Business (2020-2025) & (US$ Million)
 Table 127. DiverChim Recent Development
 Table 128. Aurora Company Details
 Table 129. Aurora Business Overview
 Table 130. Aurora Oncology Drug Discovery Services Product
 Table 131. Aurora Revenue in Oncology Drug Discovery Services Business (2020-2025) & (US$ Million)
 Table 132. Aurora Recent Development
 Table 133. HD Biosciences Company Details
 Table 134. HD Biosciences Business Overview
 Table 135. HD Biosciences Oncology Drug Discovery Services Product
 Table 136. HD Biosciences Revenue in Oncology Drug Discovery Services Business (2020-2025) & (US$ Million)
 Table 137. HD Biosciences Recent Development
 Table 138. WuXi AppTec Company Details
 Table 139. WuXi AppTec Business Overview
 Table 140. WuXi AppTec Oncology Drug Discovery Services Product
 Table 141. WuXi AppTec Revenue in Oncology Drug Discovery Services Business (2020-2025) & (US$ Million)
 Table 142. WuXi AppTec Recent Development
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Oncology Drug Discovery Services Picture
 Figure 2. Global Oncology Drug Discovery Services Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Oncology Drug Discovery Services Market Share by Type: 2024 VS 2031
 Figure 4. Identification Service Features
 Figure 5. Authentication Service Features
 Figure 6. Hit-to-lead and Lead Optimization Services Features
 Figure 7. Others Features
 Figure 8. Global Oncology Drug Discovery Services Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Oncology Drug Discovery Services Market Share by Application: 2024 VS 2031
 Figure 10. Research Institutes Case Studies
 Figure 11. Pharmaceutical Companies Case Studies
 Figure 12. Biotechnology Companies Case Studies
 Figure 13. Others Case Studies
 Figure 14. Oncology Drug Discovery Services Report Years Considered
 Figure 15. Global Oncology Drug Discovery Services Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Oncology Drug Discovery Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Oncology Drug Discovery Services Market Share by Region: 2024 VS 2031
 Figure 18. Global Oncology Drug Discovery Services Market Share by Players in 2024
 Figure 19. Global Top Oncology Drug Discovery Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Drug Discovery Services as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Oncology Drug Discovery Services Revenue in 2024
 Figure 21. North America Oncology Drug Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Oncology Drug Discovery Services Market Share by Country (2020-2031)
 Figure 23. United States Oncology Drug Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Oncology Drug Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Oncology Drug Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Oncology Drug Discovery Services Market Share by Country (2020-2031)
 Figure 27. Germany Oncology Drug Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Oncology Drug Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Oncology Drug Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Oncology Drug Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Oncology Drug Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Oncology Drug Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Oncology Drug Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Oncology Drug Discovery Services Market Share by Region (2020-2031)
 Figure 35. China Oncology Drug Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Oncology Drug Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Oncology Drug Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Oncology Drug Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Oncology Drug Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Oncology Drug Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Oncology Drug Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Oncology Drug Discovery Services Market Share by Country (2020-2031)
 Figure 43. Mexico Oncology Drug Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Oncology Drug Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Oncology Drug Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Oncology Drug Discovery Services Market Share by Country (2020-2031)
 Figure 47. Turkey Oncology Drug Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Oncology Drug Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Oncology Drug Discovery Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Charles River Revenue Growth Rate in Oncology Drug Discovery Services Business (2020-2025)
 Figure 51. Evotec Revenue Growth Rate in Oncology Drug Discovery Services Business (2020-2025)
 Figure 52. GE Healthcare Life Sciences Revenue Growth Rate in Oncology Drug Discovery Services Business (2020-2025)
 Figure 53. GenScript Revenue Growth Rate in Oncology Drug Discovery Services Business (2020-2025)
 Figure 54. Horizon Discovery Revenue Growth Rate in Oncology Drug Discovery Services Business (2020-2025)
 Figure 55. TCG Lifesciences Revenue Growth Rate in Oncology Drug Discovery Services Business (2020-2025)
 Figure 56. Zumutor Revenue Growth Rate in Oncology Drug Discovery Services Business (2020-2025)
 Figure 57. ChemPartner Revenue Growth Rate in Oncology Drug Discovery Services Business (2020-2025)
 Figure 58. Aquila BioMedical Revenue Growth Rate in Oncology Drug Discovery Services Business (2020-2025)
 Figure 59. Onconova Revenue Growth Rate in Oncology Drug Discovery Services Business (2020-2025)
 Figure 60. Vichem Chemie Revenue Growth Rate in Oncology Drug Discovery Services Business (2020-2025)
 Figure 61. GVK Biosciences Revenue Growth Rate in Oncology Drug Discovery Services Business (2020-2025)
 Figure 62. NuChem Therapeutics Revenue Growth Rate in Oncology Drug Discovery Services Business (2020-2025)
 Figure 63. Syncom Revenue Growth Rate in Oncology Drug Discovery Services Business (2020-2025)
 Figure 64. Envigo Revenue Growth Rate in Oncology Drug Discovery Services Business (2020-2025)
 Figure 65. DiverChim Revenue Growth Rate in Oncology Drug Discovery Services Business (2020-2025)
 Figure 66. Aurora Revenue Growth Rate in Oncology Drug Discovery Services Business (2020-2025)
 Figure 67. HD Biosciences Revenue Growth Rate in Oncology Drug Discovery Services Business (2020-2025)
 Figure 68. WuXi AppTec Revenue Growth Rate in Oncology Drug Discovery Services Business (2020-2025)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS